A Study Assessing The Effect Of Cobicistat Versus Ritonavir On Darunavir And Dolutegravir Exposure In HIV-Infected Patients Switching From Darunavir/Ritonavir To Darunavir/Cobicistat With Dolutegravir Given As Part Of Their Antiretroviral Therapy

Trial Profile

A Study Assessing The Effect Of Cobicistat Versus Ritonavir On Darunavir And Dolutegravir Exposure In HIV-Infected Patients Switching From Darunavir/Ritonavir To Darunavir/Cobicistat With Dolutegravir Given As Part Of Their Antiretroviral Therapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Apr 2017

At a glance

  • Drugs Cobicistat/darunavir (Primary) ; Dolutegravir (Primary) ; Darunavir/ritonavir
  • Indications HIV infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 06 Apr 2017 New trial record
    • 16 Feb 2017 Results presented at the 24th Conference on Retroviruses and Opportunistic Infections.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top